Effects of the concomitant administration of tamsulosin (0.8 mg) on the pharmacokinetic and safety profile of intravenous digoxin (LANOXIN) in normal healthy subjects: a placebo-controlled evaluation.

A 20-day, nonrandomized, open-label, placebo-controlled study was performed to investigate whether concomitant administration of tamsulosin (0.8 mg) affects the pharmacokinetic and safety profile of intravenous digoxin (0.5 mg) in healthy subjects. Ten healthy subjects aged 21-39 years received a si...

Full description

Bibliographic Details

Published in:	Journal of Clinical Pharmacy & Therapeutics Vol. 27; no. 1; pp. 13 - 20
Main Authors:	Miyazawa Y, Starkey LP, Forrest A, Schentag JJ, Kamimura H, Swarz H, Ito Y
Format:	research tables/charts Journal Article
Published:	Wiley-Blackwell Feb2002
Online Access:	View this record in EBSCOhost